| Literature DB >> 28476210 |
J Ceccaldi1, J-B Thibert2, A Haddad3, M-C Bouësseau4, R Pottier5, B Danic2, S Noël6, M Monsellier7, J-D Tissot8, T Sannié9, B Clavier10, M-F Mamzer11, J-P Cartron12, J-P Vernant12, C Hervé13, O Garraud14.
Abstract
The not-for-profit issue has been debated in November 2016 in Paris; this issue is one of the four canonical pillars of ethical blood donation. It is intimately bound to benevolence though it is distinct, as not-for-profit calls for institutions while benevolence calls for individuals. It is indeed intended that voluntary blood donors do not benefit from their donation and are thus non-remunerated. Not-for-profit is essential since it refers to the public character of blood as a putative public resource aimed at being shared as a tribute of solidarity. A central question however is linked to the capacity- or not -of public sectors to ensure that blood components are universally available, with special mention to plasma derived drugs, without the contribution of the for profit, private sector.Entities:
Keywords: Benevolence; Bénévolat; Ethics; Médicaments dérivés du plasma; Non-profit; Not-for-profit; Plasma-derived drugs; Transfusion; Éthique
Mesh:
Year: 2017 PMID: 28476210 DOI: 10.1016/j.tracli.2017.04.003
Source DB: PubMed Journal: Transfus Clin Biol ISSN: 1246-7820 Impact factor: 1.406